Last reviewed · How we verify
Antiseptic preparation — Treatment Landscape & Competitive Intelligence
4 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Betaprone | PROPIOLACTONE | Allergan/AbbVie | propiolactone | 1982-01-01 | ||
| Ablysinol | Ethanol | Qol Medcl | ethanol | GABA A receptor alpha-4/beta-2/delta | 1946-01-01 | |
| DECA | DECA | Baylor College of Medicine | ||||
| Boric | Boric | Indian Council of Medical Research |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 10 drugs in Antiseptic preparation
- Allergan/AbbVie · 1 drug in Antiseptic preparation
- Baylor College of Medicine · 1 drug in Antiseptic preparation
- Indian Council of Medical Research · 1 drug in Antiseptic preparation
- Qol Medcl · 1 drug in Antiseptic preparation
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Antiseptic preparation:
- Antiseptic preparation treatment updates — RSS
- Antiseptic preparation treatment updates — Atom
- Antiseptic preparation treatment updates — JSON
Cite this brief
Drug Landscape (2026). Antiseptic preparation — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/antiseptic-preparation. Accessed 2026-06-10.
Related
- Antiseptic preparation full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing